18 June 2018
MEDIA RELEASE: National Student Business Plan Competition – Quarter Finalists Announced
Entrants in the Pharmacy Guild of Australia’s annual National Student Business Plan Competition, an Australia-wide challenge aiming to encourage innovation amongst pharmacy students, have been advised that nine teams will progress through to the quarter-final round.
The nine teams awarded places in the quarter finals are from five different universities in Australia and New Zealand – University of Technology Sydney, University of Tasmania, University of Sydney, University of Auckland and University of Otago.
Teams were required to develop two innovative services to implement in their pharmacies. One service had to be ‘new to the market’ or ‘highly differentiated’ from something already on offer, and the other one offering a social or community benefit.
Some of the innovative ideas developed aimed to tackle challenges such a mental health and sleep issues in rural locations, allergy testing, sexual health in youth, and medication management. All plans developed holistic and community focused programs, utilising new and exciting technologies.
The quarter-final round commenced on the 18 June and concludes on the 1 July 2018. The successful teams will progress through to the semi-final round, and compete for a chance to be selected as finalists: receiving complimentary registration, travel and accommodation to attend Pharmacy Connect in Sydney in September.
The National Student Business Plan Competition is designed to promote creative entrepreneurship among pharmacy students and encourage the development of viable, innovative, pharmacist-owned community pharmacies.
It gives Australia’s and New Zealand’s best and brightest pharmacy students an opportunity to demonstrate their understanding of pharmacy practice through innovative and financially secure business models.
The competition is an initiative of the Pharmacy Guild of Australia and is sponsored by Sanofi Consumer Healthcare (Principal Sponsor), EBOS (Major Sponsor) Gold Cross Products and Services and Pharmaceutical Defence Limited (PDL).
Media inquiries: Greg Turnbull 0412 910261